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Dental pathologies can be caused by plaque-forming bacteria and yeast, which reside in the oral cavity. The bacteria growing in
dental plaque, a naturally occurring bioﬁlm, display increased resistance to antimicrobial agents. The objective was the evaluation
of a preclinical assay of medicinal plants of the semiarid region from the northeast against oral pathogenic microorganism, aiming
at bioprospecting a new product. The selection of plant material for this study was based on the ethnobotanical data on the
traditional use of plants from the semiarid region. The thirty extracts were subjected to the determination of antibioﬁlm activity
against gram-positive, gram-negative bacteria and yeast. The hydroalcoholic extract which showed positive antibioﬁlm activity
against most of the microorganisms tested in agar diﬀusion assay was further tested for the determination of minimum inhibitory
concentration (MIC) and Bioassay with Artemia salina. Plant samples tested in this study exhibited good antibioﬁlm activity for
the treatment of oral problems. The Schinopsis brasiliensis showed greater activity for Pseudomonas aeruginosa and Staphylococcus
aureus, but toxicity against Artemia salina.
1.Introduction
Dental caries, periodontal disease, and candidiasis are im-
portant dental pathologies aﬀecting humankind. These
conditions are caused by plaque-forming bacteria and yeast,
which reside in the oral cavity. Periodontal diseases have
mainly been associated with Actinomyces, Actinobacillus,
Streptococcus,a n dCandida species [1]. It is generally rec-
ognized that the bacterial growth in bioﬁlms imparts a
substantial decrease in susceptibility to antimicrobial agents
compared with cultures grown in suspension. It is therefore
not surprising that bacteria growing in dental plaque, a
naturally occurring bioﬁlm, display increased resistance to
antimicrobial agents [2].
The resistance development by pathogens to the existing
pharmaceutical has led to the intensiﬁcation of the search
for novel drugs, against fungal, parasitic, bacterial, and viral
infections. Plant-derived antimicrobials have a long history
of providing the much needed novel therapeutics. A number
of traditionally used medicinal plants have to date been
screened for various biological activities in both in vivo and
in vitro models. The chemical investigation from medicinal
plants purported to have medicinal properties has yielded
numerous puriﬁed compounds which have proven to be
indispensable in the practice of modern medicine [3].
Brazil has a great potential for biodiversity and wealth of
traditional knowledge accumulated by local people who have
direct access to nature and the products of biodiversity. In
this sense, the Caatinga, main semiarid’s biome, represents
the fourth largest area covered by a single vegetation form in
Brazil, accounting for about 60% of the northeast territory.
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regarding the medicinal plants within the Caatinga area, and
some publications describe the rich ﬂora of this region as
having many medicinal purposes [4].
This work aims at the evaluation of a preclinical assay
of medicinal plants from the folk medicine of the semiarid
region of the northeast against oral pathogenic microorgan-
isms, in order to bioprospect a new product.
2.MaterialsandMethods
2.1. Plant Materials. The medicinal plants were collected
from the semiarid region in the State of Para´ ıba. Voucher
specimenwerepreparedandidentiﬁedattheProfessorJayme
Coelho de Morais Herbarium (PRU), Federal University of
Paraiba and at the D´ ardamo de Andrade Lima herbarium
Agronomic Institute of Pernambuco (Table 1).
2.2. Extracts Preparation. The plant material was air dried at
40◦C and ground to a ﬁne powder. The powdered material
(200g) was extracted with 1000mL ethanol/distilled water
with 10, 20, 30, 50, and 70% (v/v) for 5 days with occasional
stirring, accordingly named as HEx1, HEx2, HEx3, HEx4,
and HEx5, respectively, and stored at room temperature in
amber ﬂasks.
2.3. Antibioﬁlm Activity. The microorganisms used in this
study included Pseudomonas aeruginosa (ATCC 27853),
Streptococcus mutans (ATCC 25175), Streptococcus salivarius
(ATCC 7073), Streptococcus oralis (ATCC 10557), Lactobacil-
lus casei (ATCC 7469), Enterococcus faecalis (ATCC 29212),
Staphylococcus aureus (ATCC 25923), Candida albicans
(ATCC 18804), Candida tropicalis (ATCC 13803), Candida
krusei (ATCC 34135). Bacteria were grown in the Mueller
Hinton agar medium with 5% blood agar under anaerobic
conditions in anaerobic jar, at 37◦C for 48h. Sabouraud
Dextrose Agar medium was used for culturing Candidas at
25◦C for 24h under aerobic conditions.
2.3.1. Cylinder-Plate Assay. The microorganisms were indi-
vidually inoculated into tubes containing 5mL sterile 0.9%
saline solution. The suspension was adjusted spectrophoto-
metricallyat625nmwhichisequivalentto106 CFU/mL.The
agar was composed of 2 separate layers, and only the upper
layer was inoculated. The Mueller Hinton agar (20mL)
was poured into microbiological Petri dish (100mm ×
20mm) for the base layer. After solidiﬁcation, the other
layer containing 5mL inoculated medium, with the diﬀerent
microorganisms, was distributed to the surface of each base
layer. For the 5 × 1 design, six stainless-steel cylinders of
uniform size (8mm × 6mm× 10mm) were placed on the
surface of inoculated agar, and an exactly measured volume
(100µL) of the corresponding extract was deposited into
ﬁve cylinders, while the other one was ﬁlled with either the
standard solution. In the bioassay, ten plates were prepared.
All plates were left for 2 hour at room temperature and then
incubated at 37
◦C ± 1◦C (for bacteria) for 24h and 30
◦C ±
1◦C (for yeast) for 24h. The diameter (in mm) of growth
inhibition zones was carefully measured using a caliper with
at least 0.1mm accuracy.
2.3.2. Minimal Inhibitory Concentration (MIC) Determina-
tion. The assay was performed by the broth microdilution
method. It was performed in 96 well microplates according
to the Clinical and Laboratory Standards Institute [27]
procedures. The inoculums were standardized in tubes con-
taining 5mL sterile 0.9% saline solution. The suspension
was adjusted spectrophotometrically at 625nm which is
equivalent to 106 CFU/mL. One hundred microlitres of each
hydroalcoholic extract were serially diluted threefold with
sterile Mueller Hinton broth or with sterile Sabouraud
Dextrosebrothina96-wellmicrolitreplateforeachmicroor-
ganisms strains studied. A similar threefold serial dilution
of chlorhexidine was used as a positive control against each
bacterium and nystatin against each Candida. One hundred
microlitres of each microorganism culture were added to
each well. Ethanol/water was included as negative controls.
The plate incubated at 37
◦C ± 1◦C (for bacteria) for 24h
and 30
◦C ± 1◦C (for yeast) for 24h. Bacterial growth was
indicated by adding 20µL of aqueous solution of resazurin
(Sigma-Aldrich) to 0.01% with further incubation at 37
◦C±
1◦C for 2h. Viable bacteria reduced the yellow dye to a pink
color. The MIC was deﬁned as the lowest concentration that
inhibited the colour change of resazurin.
2.4. Bioassay with Artemia salina. This bioassay was per-
formed with extracts that showed antibioﬁlm activity to
evaluate the EtOH extract toxicity; it used the brine shrimp
(Artemia salina) lethality test. The 50g of eggs of A. salina
were incubated in sea water (pH 8 ± 0,5 and 28◦C) at
artiﬁcial light during 24–36 hours for cysts occlusion and
larvae obtaining. After hatching, they were collected and put
into tubes containing diﬀerent EtOH extract concentrations
(2000, 1500, 1000, 500, and 250µg/mL), and the blank
control was always conduced. The set was incubated at
artiﬁcial light for 24h, and then the survivor larvae were
countedtodeterminetheLC50usingtheProbitmethod.The
bioassay was repeated three times. As the measure of extract
toxicity, the LC50 value lower than 1000µg/mL is considered
bioactive [28].
2.5. Statistical Analysis. The results were expressed as mean.
Diﬀerences among means were statistically compared using
the Student’s t-test for antibioﬁlm assay. The values were
considered signiﬁcantly diﬀerent when P<0.05. The
softwareusedwastheOriginsoftware.TheLC50forBioassay
with A. salina was determined according to the Probit
statistical method using the software STATPLUS 2005.
3. Results and Discussion
3.1. Antibioﬁlm Activity. The selection of plant material
for this study was based on the ethnobotanical data on
the traditional use of plants from the semiarid region.
The thirty extracts were subjected to the determination
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Table 1: Dada ethnobotanical investigated plants.
Scientiﬁc name Popular name Family Part used Herbarium number Popular use Reference
A. hispidum DC. Carrapicho-de-cigano Asteraceae EP EAN-10957
Cough, respiratory problem,
diuretic, diarrhea, sinusitis,
malaria, infection in general,
bronchitis and intestinal
problems, typhus.
[4–11]
A. coriacea L. Araticum Annonaceae SB IPA21443 Stomach problems, diarrhea,
and malaria. [12, 13]
H. mutabilis Briq. Alfavaca-de-caboclo Lamiaceae L EAN-10699
Stomach problems, sudoriﬁc,
expectorant, calmative,
uterine inﬂammation, gastric
ulcer, inﬂuenza, fever, cough,
headache, rheumatism.
[6, 10, 14–18]
S. brasiliensis Engl. Bra´ una Anacardiacea SB EAN-14049 Cough, inﬂuenza, diarrhea,
fractures, sexual impotence. [5, 6, 10, 19, 20]
X. americana L. Ameixa Olacaceae SB EAN-100493
Antiseptic, malaria, toothache,
skin urinary infection,
diarrhea, asthma, anemia,
inﬂammation, ﬁbroids, sleep
diseases, ulcer, gastritis,
Fractures, cancer, itching.
[6, 21–26]
R: root; SB: stem-bark; L: leaves; EP: entire plant.
bacteria and yeast (Table 2). The extracts of H. mutabilis
and A. coriacea presented no inhibitory activity against the
microorganisms tested, but Toledo et al. [29] showed that
theextractobtainedfromA.coriaceashowedthebestactivity
against Candida albicans and C. parapsilosis.A l le x t r a c t s
exhibited antibacterial activity against S. oralis. The growth
of S. mutans, S. salivarius, L. casei, C. albican, C. tropicalis,
and C. krusei was not inhibited by any concentration of
extracts tested.
The A. hispidum extract presented activity only against
S. oralis. The study conducted by Ederwor and Olajire [30]
conﬁrms the antimicrobial activity of the extracts of P.
aeruginosa and S. aureus.
The X. americana bark extract showed activity against
E. faecalis, S. aureus,a n dS. oralis. The zones of inhibition
observed at E. faecalis were statistically diﬀerent compared
with those of chlorhexidine (positive control). And for
another bacterium, the chlorhexidine presented bigger inhi-
bition halo than that promoted by the E. faecalis and S.
aureus. Costa et al. [31] demonstrated the antimicrobial
activity of the X. americana bark extracts at E. faecalis
and showed that they may represent alternative substances
in endodontic treatment. And in another study Falc˜ ao
and Menezes [32] observed that C. albicans was the least
susceptible among the tested yeast.
The best results were obtained with S. brasiliensis extract
against S. aureus. This extract presents higher eﬃcacy in the
HEx5 for P. aeruginosa, Hex1–Hex4 for S. aureus,a n dH e x 1 –
Hex3 for S. oralis compared with chlorhexidine. This result
was consistent with that discussed by Goleniowski et al. [14]
and de Barros et al. [15]. This conﬁrmed that antibioﬁlm
activity can be related to the higher proportion of tannins
and ﬂavonoids in the plant like the observed by Siqueira et
al. [33].
The hydroalcoholic extract which showed positive
antibioﬁlm activity against most of the microorganisms
tested in agar diﬀusion assay was further tested for the
determination of minimum inhibitory concentration (MIC)
and Bioassay with Artemia salina.
3.2. Minimal Inhibitory Concentration (MIC) Determination.
Minimum inhibitory concentrations (MICs) of extracts for
antibioﬁlmactivityweredeterminedusingthemicrodilution
bioassay as described by CLSI [27]( Table 3).
Studies showed that the MIC values indicate that S.
brasiliensis extract was more eﬃcient, corroborating the
results of the previous experiment. The important activity
on S. aureus conﬁrms the best activity obtained in cylinder-
plate assay, which revealed this strain as one of the most
susceptiblewithMICrangingfrom0.250to0.063µL/µL.The
S. oralis strain was the least sensitive (MIC = 1.000µL/µL).
The P. aeruginosa HEx1 was the most sensitive (MIC =
0.004µL/µL). Similar result was found by Goleniowski et al.
[14]a n dd eB a r r o se ta l .[ 15].
The X. americana extract presented activity against S.
aureus (MIC = 0.250–0.063µL/µL), E. faecalis (MIC =
1.000µL/µL), and S. oralis (MIC = 1.000µL/µL). Omer and
Elnima [34] reported activity of the methanolic and aqueous
extract against S. aureus. Kon´ e et al. [35] demonstrated that
the ethanolic root extract exhibited some activity against S.
aureus and E. faecalis.
3.3. Bioassay with Artemia salina. Determination of the
toxicity to Artemia salina has been used eﬃciently to analyze4 Evidence-Based Complementary and Alternative Medicine
Table 2: Antimicrobial activity of plants tested against oral microorganisms.
Hydroalcoholic extract
Zones of inhibition (mm)
Bacterial strains Fungal strains
P.a. E.f. S.a. S.m. S.o. S.s. L.c. C.a. C.t. C.k.
Acanthospermum hispidum
HEx1 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0
HEx2 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0
HEx3 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0
HEx4 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0
HEx5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ximenia americana
HEx1 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0
HEx2 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0
HEx3 0.0 14.1 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0
HEx4 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0
HEx5 0.0 0.0 12.6 0.0 11.2 0.0 0.0 0.0 0.0 0.0
Schinopsis brasiliensis
HEx1 17.3 0.0 25.1 0.0 14.7 0.0 0.0 0.0 0.0 0.0
HEx2 16.6 0.0 27.9 0.0 14.8 0.0 0.0 0.0 0.0 0.0
HEx3 16.9 10.8 33.2 0.0 14.0 0.0 0.0 0.0 0.0 0.0
HEx4 17.0 10.3 30.4 0.0 10.5 0.0 0.0 0.0 0.0 0.0
HEx5 18.0 0.0 12.4 0.0 11.2 0.0 0.0 0.0 0.0 0.0
Chlorhexidine 19.7 13.4 16.0 13.0 12.6 12.5 12.3 — — —
Nistatine — — — — — — — 23.2 22.0 23.2
P.a.: P. aeruginosa; E.f.: E. faecalis; S.a.:S. aureus; S.m.:S. mutans; S.o.:S. oralis; S.s.: S. salivarius; L.c.: L. Casei; C.a.:C. albicans; C.t.:C. tropicalis; C.k.:C. krusei.
Table 3: Mean MIC results of selected plants on oral microorganisms.
Hydroalcoholic extract
MIC (µL/µL)
Microorganisms tested
P.a. E.f. S.a. S.o.
Acanthospermum hispidum
HEx1 — — — 1.000
HEx2 — — — 1.000
HEx3 — — — 1.000
HEx4 — — — 1.000
Ximenia americana
HEx1 — — 0.063 —
HEx2 — — 0.063 —
HEx3 — 1.000 0.063 —
HEx4 — — 0.250 —
HEx5 — — 0.250 1.000
Schinopsis brasiliensis
HEx1 0.004 — 0.063 0.500
HEx2 0.500 — 0.063 1.000
HEx3 1.000 1.000 0.063 0.500
HEx4 0.063 1.000 0.063 0.500
HEx5 0.063 — 0.063 0.500
P.a.: P. aeruginosa; E.f.: E. faecalis; S.a.: S. aureus; S.o.: S. oralis.Evidence-Based Complementary and Alternative Medicine 5
the biological potential of plant extracts. Several natural
compounds, particularly substances with antitumoral, anti-
microbial, insecticidal, and antitrypanosomal activity, have
been tested through these bioassays showing signiﬁcant
correlation [36].
The results showed that the extract of A. hispidum pre-
sentedLC50 =4.101µg/mL,S.brasiliensisLC50 =428µg/mL,
and X. americana LC50 = 4.262. Meyer et al. [28]d e s c r i b e d
a lethal concentration (LC50) based on the toxicity of
substances to the larvae of A. salina. According to the scale,
LC50 values < 500µg·mL−1 indicate toxicity, LC50 between
500 and 1000µg·mL−1 denote moderate toxicity, while LC50
> 1000µg·mL−1 suggest lack of toxicity.
In this work S. brasiliensis showed data that indicate toxi-
city. The study conducted by de Barros et al. [15]c o n ﬁ r m s
the possible plant toxicity. It was related that this can be
explained by the high concentration of polyphenols (tannin,
ﬂavonoids, and other phenolics compounds) present in this
plant and which are well known for their toxicity against A.
salina.
4. Conclusion
Plant samples tested in this study exhibited good antibioﬁlm
activity for the treatment of oral problems. The S. brasiliensis
showed higher activity for P. aeruginosa and S. aureus, but
toxicity against Artemia salina. The result suggests that stud-
ies to isolate and characterize the antibioﬁlm compounds of
S. brasiliensis Engl, whereas their high antibacterial activity
could be the base of development of new phytotherapic
product with broad spectra. Studies in vivo of toxicity are
essential.
Thisreinforcestheconceptthattheethnobotanicalinves-
tigation of used plants is necessary since it will reveal a great
number of positive responses in in vitro tests.
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